chr4-80286410-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004464.4(FGF5):c.545A>G(p.Glu182Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF5 | NM_004464.4 | c.545A>G | p.Glu182Gly | missense_variant | 3/3 | ENST00000312465.12 | NP_004455.2 | |
FGF5 | NM_001291812.2 | c.116A>G | p.Glu39Gly | missense_variant | 3/3 | NP_001278741.1 | ||
FGF5 | NM_033143.2 | c.*69A>G | 3_prime_UTR_variant | 2/2 | NP_149134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF5 | ENST00000312465.12 | c.545A>G | p.Glu182Gly | missense_variant | 3/3 | 1 | NM_004464.4 | ENSP00000311697.7 | ||
FGF5 | ENST00000456523.3 | c.*69A>G | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000398353.3 | ||||
FGF5 | ENST00000503413.1 | n.494A>G | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
FGF5 | ENST00000507780.1 | n.342+11398A>G | intron_variant | 3 | ENSP00000423903.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.545A>G (p.E182G) alteration is located in exon 3 (coding exon 3) of the FGF5 gene. This alteration results from a A to G substitution at nucleotide position 545, causing the glutamic acid (E) at amino acid position 182 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.